Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin

[1]  P. Chapman,et al.  Visualising E-selectin in the detection and evaluation of inflammatory bowel disease , 1998, Gut.

[2]  A. George,et al.  Expression of recombinant anti-E-selectin single-chain Fv antibody fragments in stably transfected insect cell lines. , 1998, Journal of immunological methods.

[3]  C. Miller,et al.  Characterization of an Adenovirus Vector Containing a Heterologous Peptide Epitope in the HI Loop of the Fiber Knob , 1998, Journal of Virology.

[4]  K. Zinn,et al.  Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5) , 1998, Gene Therapy.

[5]  D. Brough,et al.  Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins , 1997, Journal of virology.

[6]  I. Kovesdi,et al.  Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation , 1997, Cancer Immunology, Immunotherapy.

[7]  David D Spragg,et al.  Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Curiel,et al.  Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells , 1997, The EMBO journal.

[9]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[10]  R. Crystal,et al.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. , 1997, Human gene therapy.

[11]  S. Licence,et al.  The role of E-selectin in lymphocyte and polymorphonuclear cell recruitment into cutaneous delayed hypersensitivity reactions in sensitized pigs. , 1996, Journal of immunology.

[12]  K. Gustafsson,et al.  Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo. , 1996, Transplantation.

[13]  I. Kovesdi,et al.  Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies , 1996, Journal of virology.

[14]  F. Jamar,et al.  Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[15]  J. Leiden,et al.  Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors , 1996, Nature Medicine.

[16]  F. Jamar,et al.  Characterization of E-selectin expression, leucocyte traffic and clinical sequelae in urate crystal-induced inflammation: an insight into gout. , 1996, British journal of rheumatology.

[17]  S. Licence,et al.  In vivo E-selectin upregulation correlates early with infiltration of PMN, later with PBL entry: MAbs block both. , 1996, The American journal of physiology.

[18]  A. Gown,et al.  Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration , 1995, Nature Genetics.

[19]  Ronald W. Barrett,et al.  Peptides Which Bind to E-selectin and Block Neutrophil Adhesion (*) , 1995, The Journal of Biological Chemistry.

[20]  R. Virmani,et al.  Endothelium-specific in vivo gene transfer. , 1995, Circulation research.

[21]  Pablo Engel,et al.  The selecting: vascular adhesion molecules , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  S. Licence,et al.  Porcine E-selectin: cloning and functional characterization. , 1995, Immunology.

[23]  G. Nemerow,et al.  Multiple adenovirus serotypes use alpha v integrins for infection , 1994, Journal of virology.

[24]  M. Perricaudet,et al.  Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. , 1994, Circulation.

[25]  G. Nemerow,et al.  Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization , 1994, The Journal of cell biology.

[26]  J. Wilson,et al.  Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Kuijpers,et al.  Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process. , 1994, Journal of immunology.

[28]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Wilson,et al.  Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. , 1994, Circulation.

[30]  G. Nemerow,et al.  Integrin txv/35 Selectively Promotes Adenovirus Mediated Cell Membrane Permeabilization , 1994 .

[31]  S. Licence,et al.  Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. , 1994, The American journal of physiology.

[32]  R. Crystal,et al.  Efficient and Selective Adenovirus‐Mediated Gene Transfer Into Vascular Neointima , 1993, Circulation.

[33]  Ari Helenius,et al.  Stepwise dismantling of adenovirus 2 during entry into cells , 1993, Cell.

[34]  D. Wagner,et al.  Divergent fates of P- and E-selectins after their expression on the plasma membrane. , 1993, Molecular biology of the cell.

[35]  Mike D Cadogan,et al.  The distribution of adhesion molecules in human atherosclerosis , 1993, Histopathology.

[36]  R. Crystal,et al.  In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. , 1993, Circulation research.

[37]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[38]  G. Sicard.  Site-specific gene expression in vivo by direct gene transfer into the arterial wall: Nabel EG, Plautz G, Nabel GJ. Science 1990; 249: 1285-8 , 1993 .

[39]  J. Neefjes,et al.  Phosphorylation of surface E‐selectin and the effect of soluble ligand (Sialyl Lewisx) on the half‐life of E‐selectin , 1993, European journal of immunology.

[40]  A. Becker,et al.  Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. , 1992, The American journal of pathology.

[41]  J. Onderwater,et al.  Evidence for endocytosis of E‐selectin in human endothelial cells , 1992, European journal of immunology.

[42]  C. Benjamin,et al.  Expression of vascular adhesion molecules in inflammatory bowel disease. , 1992, Gastroenterology.

[43]  E. Everitt,et al.  Infectious entry pathway of adenovirus type 2 , 1991, Journal of virology.

[44]  B. Kirkham,et al.  Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. , 1991, The Journal of rheumatology.

[45]  D. Macdonald,et al.  Endothelial leucocyte adhesion molecule‐1 (ELAM‐1) expression in cutaneous inflammation , 1991, The British journal of dermatology.

[46]  G. Haines,et al.  Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[47]  E. Nabel,et al.  Site-specific gene expression in vivo by direct gene transfer into the arterial wall. , 1990, Science.

[48]  J. Lanchbury,et al.  A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. , 1990, Journal of immunology.

[49]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[50]  R. Cotran,et al.  Induction and detection of a human endothelial activation antigen in vivo , 1986, The Journal of experimental medicine.

[51]  D. Slater,et al.  The porcine endothelial cell in tissue culture. , 1975, Atherosclerosis.